Status: Phase 2
Entry Type: Oligonucleotide
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Carcinoma; Carcinoma, Squamous Cell; Squamous Cell Carcinoma of Head and Neck Phase 1/Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Hepatocellular Phase 1 ClinicalTrials
Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin Phase 1 ClinicalTrials
Urinary Bladder Neoplasms Phase 1 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Colorectal Neoplasms; Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Neoplasms Phase 1/Phase 2 ClinicalTrials
Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse Phase 1 ClinicalTrials
Ascites; Digestive System Neoplasms; Gastrointestinal Neoplasms; Neoplasms; Ovarian Neoplasms Phase 2 ClinicalTrials
CONTENTS